The use of digital health technology (DHT) is increasing worldwide. Clinical trials assessing available health tools for the ...

Hypertension in adolescents (aged 10–19 years) and young adults is becoming a major global health issue, largely due to ...

We evaluated the effects of digital health technologies (DHTs) on women's health, empowerment, and gender equality, using the ...

Randomised controlled trials are the gold standard to assess the effectiveness and safety of clinical interventions; however, ...

The prevalence of SVAC is extremely high for both females and males across the globe. Given data sparsity and ongoing ...

Many African countries have long relied on overseas development aid to implement health programmes. Unfortunately, this aid has fostered dependency and fragmentation, often introducing vertical ...

Although much remains to be done, tremendous progress has been made on the prevention and control of chronic non-communicable diseases (NCDs), with slow but steady health gains achieved for millions ...

WHO's new guideline advocating for the switch from regular salt (sodium chloride) to potassium-enriched salt substitutes marks a transformative step in global efforts to reduce hypertension, stroke, ...

More than 50 years have passed since the discovery of fluoxetine, better known by its trade name Prozac. Together with the ...

The detection of incidental adrenal nodules is increasing as a direct result of widespread abdominal imaging, and mild ...

We would like to thank Xin Yu Yang and colleagues for their interest in our Clinical Picture1 and for highlighting the diagnostic challenges of congenital syphilis in their comments.

Donald Trump has promised to create a pro-AI environment, but even tech companies are frustrated by federal cuts that hamper regulatory processes. Paul Webster reports.